Jpmorgan Chase & Co »

Mersana Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.0M 2.0M 2.01
2024-03-31 $6.4M 1.4M 4.48
2023-12-31 $183k 79k 2.32
2023-09-30 $339k 267k 1.27
2023-06-30 $4.8M 1.4M 3.29
2023-03-31 $1.4M 6.7k 204.22
2022-12-31 $2.3M 387k 5.86
2022-06-30 $2.1M 451k 4.61
2022-03-31 $1.3M 310k 4.05
2021-12-31 $197k 32k 6.23
2021-03-31 $2.3M 142k 16.18
2020-12-31 $4.6M 174k 26.61
2020-09-30 $3.9M 207k 18.80
2020-06-30 $5.3M 225k 23.40
2020-03-31 $2.6M 447k 5.82
2019-12-31 $3.9M 678k 5.73
2019-09-30 $1.5M 929k 1.57
2019-06-30 $3.3M 814k 4.07
2019-03-31 $4.3M 823k 5.26
2018-12-31 $1.7M 425k 4.08
2018-09-30 $3.2M 318k 10.00
2018-06-30 $5.3M 294k 17.86
2018-03-31 $4.9M 308k 15.78
2017-12-31 $5.5M 334k 16.43
2017-06-30 $4.8M 341k 13.97